News|Articles|March 6, 2024
High Resolution Methods for Clinical Biomarker Validation
Author(s)Sannova Analytical
Discover how high-resolution biomarker assays such as Meso Scale Discovery (MSD) and advanced Mass Spectrometry (MS) go beyond the limitations of traditional ELISA assays, and how they overcome central challenges in biomarker assessment and ligand binding assays (LBAs).
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
2
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
3
How Mitigation and Maintenance Protect Against Future Risk
4
Behind the Headlines Episode 29: 2025 Year in Review
5
